Michael J. Kelley, MD

Articles by Michael J. Kelley, MD

Lung Cancer Management in 2010

ByApar Kishor Ganti, MD, MS,Chao H. Huang, MD,Mark A. Klein, MD,Sean Keefe, PharmD,Michael J. Kelley, MD

January 15th 2011

Exciting advances in understanding the biology of lung cancer have occurred over the last few years.

Autocrine Growth Factors and Neuroendocrine Markers in the Development of Small-Cell Lung Cancer

ByBruce E. Johnson, MD,Michael J. Kelley, MD

January 2nd 1997

Two different clinical trials using biological agents directed against an autocrine growth factor and a surface marker of neuroendocrine differentiation have been used for patients with relapsed small-cell lung cancer. In a

Latest Updated Articles

Autocrine Growth Factors and Neuroendocrine Markers in the Development of Small-Cell Lung Cancer
January 2nd 1997
Lung Cancer Management in 2010
January 15th 2011

Trending on CancerNetwork

Melanoma Vaccine Receives FDA Fast Track Designation

NCCN Guidelines Recommend Taletrectinib for ROS1+ NSCLC Subtype

Targeting NAMPT and KRAS in Pancreatic Ductal Adenocarcinoma

145 Racial Differences in Outcomes and Health Care Utilization Among Patients With HR-Positive, HER2-Negative Metastatic Breast Cancer Treated With CDK4/6 Inhibitors: A Real-World Analysis